000045136 000__ 01046cam\a22003735i\4500
000045136 001__ 45136
000045136 003__ SzGeWIPO
000045136 005__ 20240708150100.0
000045136 006__ m\\\\eo\\d\\\\\\\\
000045136 007__ cr bn |||m|||a
000045136 008__ 220304s2021\\\\nyu\\\\\o\\\\\000\0\eng\d
000045136 035__ $$a(OCoLC)1313806366
000045136 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000045136 041__ $$aeng
000045136 24503 $$aAn Organic Solution to an Artificial Problem: How an FDA Regulatory Scheme Can Protect AI Innovation in Healthcare.
000045136 264_1 $$a[New York, NY] :$$bThomson Reuters,$$c2021
000045136 300__ $$a1 online resource
000045136 336__ $$atext$$2rdacontent
000045136 337__ $$acomputer$$2rdamedia
000045136 338__ $$aonline resource$$bcr$$2rdacarrier
000045136 4901_ $$aAIPLA Quarterly Journal,$$x0883-6078 ;$$vSummer, 2020 Volume 48 ,Issue 2
000045136 542__ $$fhttps://1.next.westlaw.com/Copyright
000045136 588__ $$aCrossref
000045136 590__ $$aPublished online: 1-Aug-20
000045136 650_0 $$aPatents
000045136 650_0 $$aMedical technology -- Law & legislation
000045136 7001_ $$aKretzschmar, Caitlyn E.
000045136 7731_ $$tAIPLA Quarterly Journal
000045136 7731_ $$wAIPLA Q.J.
000045136 830_0 $$aAIPLA Quarterly Journal,$$vSummer, 2020 Volume 48 ,Issue 2.
000045136 85641 $$uhttps://www.westlaw.com/Document/I4c0b183abff511ebbea4f0dc9fb69570/View/FullText.html?transitionType=Default&contextData=(sc.Default)&VR=3.0&RS=cblt1.0&sp=wlnintell-000$$yonline version
000045136 904__ $$aJournal article
000045136 980__ $$aAIPLA